title: Long-term outcomes of percutaneous nephrolithotomy in 177 patients with chronic kidney disease: a single center experience.
abstract: OBJECTIVE
  We evaluated the long-term outcomes of percutaneous nephrolithotomy in patients with chronic kidney disease.
  
  
  METHODS
  Data on 1,904 patients who underwent percutaneous nephrolithotomy between 2002 and 2011 were retrospectively collected. The estimated glomerular filtration rate for each patient was retrospectively calculated using a 4-variable modification of diet in renal disease equation. Patients were staged for chronic kidney disease by National Kidney Foundation guidelines.
  
  
  RESULTS
  A total of 242 patients (12.7%) had a preoperative glomerular filtration rate of less than 60 ml per minute/1.73 m(2). Those monitored a minimum of 1 year were included in analysis. The study included 177 patients with a mean ± SD age of 54.3 ± 12.1 years. Perioperative and postoperative complications were noted in 15.2% of patients. At a mean followup of 43.4 ± 22.7 months renal function in 29.4% of patients had improved but it remained the same or deteriorated in 54.2% and 16.4%, respectively. On multivariate regression analysis diabetes and preoperative or postoperative complications predicted renal function. The stone-free rate 3 months postoperatively was 80.2% (142 of 177 cases). Stones recurred during long-term followup in 36 of these patients (25.3%). Spontaneous stone passage was detected in 12 of the 35 patients (34.2%) with residual stones but 8 (22.8%) with residual stones experienced an increase in stone size.
  
  
  CONCLUSIONS
  At long-term followup renal function was maintained or improved in greater than 80% of patients with chronic kidney disease who underwent percutaneous nephrolithotomy. Stones recurred or residual stones grew in approximately 25% of these patients.
authors.affiliation: Department of Urology, Haseki Teaching and Research Hospital, Istanbul, Turkey. takman36@gmail.com
authors.forename: Tolga
authors.initials: T
authors.lastname: Akman
authors.forename: Murat
authors.initials: M
authors.lastname: Binbay
authors.forename: Rahmi
authors.initials: R
authors.lastname: Aslan
authors.forename: Emrah
authors.initials: E
authors.lastname: Yuruk
authors.forename: Faruk
authors.initials: F
authors.lastname: Ozgor
authors.forename: Erdem
authors.initials: E
authors.lastname: Tekinarslan
authors.forename: Ozgur
authors.initials: O
authors.lastname: Yazici
authors.forename: Yalcin
authors.initials: Y
authors.lastname: Berberoglu
authors.forename: Ahmet Yaser
authors.initials: AY
authors.lastname: Muslumanoglu
mesh_terms: D002908:Chronic Disease; D005260:Female; D006801:Humans; D007669:Kidney Calculi / Q000150:complications / Q000503:physiopathology / Q000601:surgery*; D007674:Kidney Diseases / Q000150:complications / Q000503:physiopathology; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D009403:Nephrostomy, Percutaneous; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome